You are here » Home » Companies ยป Company Overview » Syncom Formulations (India) Ltd

Syncom Formulations (India) Ltd.

BSE: 524470 Sector: Health care
NSE: SYNCOMF ISIN Code: INE312C01025
BSE 15:24 | 24 Mar 6.00 0.01
(0.17%)
OPEN

5.82

HIGH

6.06

LOW

5.82

NSE 15:09 | 24 Mar 5.95 -0.05
(-0.83%)
OPEN

6.00

HIGH

6.10

LOW

5.85

OPEN 5.82
PREVIOUS CLOSE 5.99
VOLUME 270450
52-Week high 13.00
52-Week low 5.82
P/E 35.29
Mkt Cap.(Rs cr) 564
Buy Price 5.94
Buy Qty 878.00
Sell Price 6.00
Sell Qty 49067.00
OPEN 5.82
CLOSE 5.99
VOLUME 270450
52-Week high 13.00
52-Week low 5.82
P/E 35.29
Mkt Cap.(Rs cr) 564
Buy Price 5.94
Buy Qty 878.00
Sell Price 6.00
Sell Qty 49067.00

Syncom Formulations (India) Ltd. (SYNCOMFORMUL) - Company Information

Syncom Formulations (India) Ltd

Incorporated as a private limited company in 1988 Syncom Formulations (India) was converted into a public limited company in Jun.'92. The company set up a manufacturing facility at Palghar Thane to produce pharmaceutical formulations. Commercial production commenced in Apr.'89. Promoters are Kedarmal Bankda Vijay Kumar Bankda and Ajay Kumar Bankda.In addition to pharmaceutical formulations in the ...> More

COMPANY INFORMATION
Chairman & Wholetime Director : Kedarmal Bankda
Managing Director : Vijay Shankarlal Bankda
Independent Director : Vinod Kumar Kabra
Independent Director : Krishna Das Neema
Independent Director : Praveen Jindal
Whole-time Director : Rinki Bankda
Company Secretary : Prachi Jain
Additional Director : Ruchi Jindal
AUDITOR : Sanjay Mehta & Associates
IND NAME : Pharmaceuticals - Indian - Formulations
HOUSE NAME : Indian Private
Registered office
7 Niraj Indl Estate Andheri(E), Off Mahakali Caves Rd,Mumbai,Maharashtra-400093
Ph : 91-22-30887744
WEBSITE : http://www.sfil.in
E-mail : info@sfil.in / finance@sfil.in
.